Grey matter pathology in multiple sclerosis

被引:380
作者
Geurts, Jeroen J. G. [1 ,2 ]
Barkhof, Frederik [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Radiol, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
关键词
D O I
10.1016/S1474-4422(08)70191-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) has been classically regarded as a white matter disease. However, recent histopathological studies have convincingly shown that grey matter regions are also heavily affected. Grey matter damage starts early in the disease and substantially affects clinico-cognitive functioning. Detection of cortical grey matter lesions by use of standard MRI techniques has proved challenging, and more advanced techniques are needed. At present, the causes of grey matter damage are unclear. We review several exciting new hypotheses on grey matter pathogenesis, including meningeal inflammation as a cause of subpial cortical damage, but also selective vulnerability of neuronal subpopulations, growth factor dysregulation, glutamate excitotoxicity, mitochondrial abnormalities, and the "use-it-and-lose-it" principle. These hypotheses remain to be validated over the coming years, and could substantially affect our current views on MS pathogenesis.
引用
收藏
页码:841 / 851
页数:11
相关论文
共 139 条
[61]  
Geurts JJG, 2005, AM J NEURORADIOL, V26, P572
[62]   Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging [J].
Geurts, JJG ;
Pouwels, PJW ;
Uitdehaag, BMJ ;
Polman, CH ;
Barkhof, F ;
Castelijns, JA .
RADIOLOGY, 2005, 236 (01) :254-260
[63]   Expression patterns of group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions [J].
Geurts, JJG ;
Wolswijk, G ;
Bö, L ;
Redeker, S ;
Ramkema, M ;
Troost, D ;
Aronica, E .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 158 (1-2) :182-190
[64]   Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus:: Metabolite concentrations, quantification precision, and reproducibility [J].
Geurts, JJG ;
Barkhof, F ;
Castelijns, JA ;
Uitdehaag, BMJ ;
Polman, CH ;
Pouwels, PJW .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2004, 20 (03) :366-371
[65]   Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis [J].
Geurts, JJG ;
Wolswijk, G ;
Bö, L ;
van der Valk, P ;
Polman, CH ;
Troost, D ;
Aronica, E .
BRAIN, 2003, 126 :1755-1766
[66]   Spinal cord gray matter demyelination in multiple sclerosis -: A novel pattern of residual plaque morphology [J].
Gilmore, Christopher P. ;
Bo, Lars ;
Owens, Trudy ;
Lowe, James ;
Esiri, Margaret M. ;
Evangelou, Nikos .
BRAIN PATHOLOGY, 2006, 16 (03) :202-208
[67]   A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments [J].
Greene, YM ;
Tariot, PN ;
Wishart, H ;
Cox, C ;
Holt, CJ ;
Schwid, S ;
Noviasky, J .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (03) :350-356
[68]   Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions [J].
Huitinga, I ;
Erkut, ZA ;
van Beurden, D ;
Swaab, DF .
ANNALS OF NEUROLOGY, 2004, 55 (01) :37-45
[69]   Hypothalamic lesions in multiple sclerosis [J].
Huitinga, I ;
De Groot, CJA ;
Van Der Valk, P ;
Kamphorst, W ;
Tilders, FJH ;
Swaab, DF .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (12) :1208-1218
[70]   Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis [J].
Inglese, Matilde ;
Adhya, Sumita ;
Johnson, Glyn ;
Babb, James S. ;
Miles, Laura ;
Jaggi, Hina ;
Herbert, Joseph ;
Grossman, Robert I. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2008, 28 (01) :164-171